Bertil Ladefoged

465 total citations
19 papers, 247 citations indexed

About

Bertil Ladefoged is a scholar working on Molecular Biology, Nephrology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Bertil Ladefoged has authored 19 papers receiving a total of 247 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Nephrology and 10 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Bertil Ladefoged's work include Amyloidosis: Diagnosis, Treatment, Outcomes (13 papers), Parathyroid Disorders and Treatments (10 papers) and Peptidase Inhibition and Analysis (5 papers). Bertil Ladefoged is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (13 papers), Parathyroid Disorders and Treatments (10 papers) and Peptidase Inhibition and Analysis (5 papers). Bertil Ladefoged collaborates with scholars based in Denmark, United States and United Kingdom. Bertil Ladefoged's co-authors include Steen Hvitfeldt Poulsen, Tor Skibsted Clemmensen, Anne M. Dybro, Jonas Agerlund Povlsen, Roni Nielsen, Mads J. Andersen, Henrik Vase, Hans Eiskjær, Sara Rosengren and Sven-Olof Granstam and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Bertil Ladefoged

17 papers receiving 246 citations

Peers

Bertil Ladefoged
Bertil Ladefoged
Citations per year, relative to Bertil Ladefoged Bertil Ladefoged (= 1×) peers Angelo Giuseppe Caponetti

Countries citing papers authored by Bertil Ladefoged

Since Specialization
Citations

This map shows the geographic impact of Bertil Ladefoged's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bertil Ladefoged with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bertil Ladefoged more than expected).

Fields of papers citing papers by Bertil Ladefoged

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bertil Ladefoged. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bertil Ladefoged. The network helps show where Bertil Ladefoged may publish in the future.

Co-authorship network of co-authors of Bertil Ladefoged

This figure shows the co-authorship network connecting the top 25 collaborators of Bertil Ladefoged. A scholar is included among the top collaborators of Bertil Ladefoged based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bertil Ladefoged. Bertil Ladefoged is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ladefoged, Bertil, et al.. (2025). Atrial Fibrillation Burden, Risk Factors, and Prognosis in Wild-type Transthyretin Amyloidosis Cardiomyopathy. The American Journal of Cardiology. 254. 85–93. 1 indexed citations
2.
Ladefoged, Bertil, et al.. (2024). The Effect of Trimetazidine On Cardiac Haemodynamics and Mitochondrial Function in Wild-Type Transthyretin Amyloidosis. ESC Heart Failure. 12(3). 1796–1806. 1 indexed citations
3.
Ladefoged, Bertil, Roni Nielsen, Hans Eiskjær, et al.. (2024). Exercise Hemodynamics and Mitochondrial Oxidative Capacity in Disease Stages of Wild‐Type Transthyretin Amyloid Cardiomyopathy. Journal of the American Heart Association. 13(13). e034213–e034213.
4.
Berg‐Hansen, Kristoffer, Nigopan Gopalasingam, Bertil Ladefoged, et al.. (2024). Cardiovascular Effects of Oral Ketone Ester Treatment in Patients With Heart Failure With Reduced Ejection Fraction: A Randomized, Controlled, Double-Blind Trial. Circulation. 149(19). 1474–1489. 33 indexed citations
5.
Gopalasingam, Nigopan, Kristoffer Berg‐Hansen, Bertil Ladefoged, et al.. (2024). Randomized Crossover Trial of 2-Week Ketone Ester Treatment in Patients With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction. Circulation. 150(20). 1570–1583. 25 indexed citations
6.
Dybro, Anne M., Bertil Ladefoged, Mads J. Andersen, et al.. (2024). Effect of alcohol septal ablation on exercise hemodynamics, symptoms and quality of life in patients with obstructive hypertrophic cardiomyopathy. European Heart Journal. 45(Supplement_1).
7.
Frederiksen, Christian Alcaraz, et al.. (2024). Changes and Prognostic Implications of Myocardial Work in Aortic Stenosis Subtypes Undergoing Transcatheter Valve Implantation. SHILAP Revista de lepidopterología. 3(8). 101124–101124. 1 indexed citations
8.
Ladefoged, Bertil, et al.. (2023). Wild-type transthyretin amyloid cardiomyopathy: expect the unexpected—a case report. European Heart Journal - Case Reports. 7(9). ytad431–ytad431. 1 indexed citations
9.
Rosengren, Sara, Tor Skibsted Clemmensen, Steen Hvitfeldt Poulsen, et al.. (2023). Outcome Prediction by Myocardial External Efficiency from 11C-Acetate Positron Emission Tomography in Cardiac Amyloidosis. ESC Heart Failure. 11(1). 44–53. 3 indexed citations
10.
11.
Ladefoged, Bertil, et al.. (2023). Strain‐derived myocardial work in wild‐type transthyretin cardiac amyloidosis with aortic stenosis—diagnosis and prognosis. Echocardiography. 40(10). 1079–1087. 3 indexed citations
12.
Ladefoged, Bertil, Anne M. Dybro, Torsten B. Rasmussen, et al.. (2022). Incidence and Predictors of Worsening Heart Failure in Patients with Wild-Type Transthyretin Cardiac Amyloidosis. ESC Heart Failure. 9(5). 2978–2987. 10 indexed citations
13.
Dybro, Anne M., Torsten B. Rasmussen, Roni Nielsen, et al.. (2022). Effects of Metoprolol on Exercise Hemodynamics in Patients With Obstructive Hypertrophic Cardiomyopathy. Journal of the American College of Cardiology. 79(16). 1565–1575. 26 indexed citations
14.
Ladefoged, Bertil, Tor Skibsted Clemmensen, Anne M. Dybro, et al.. (2022). Identification of Wild-Type Transthyretin Cardiac Amyloidosis in Patients with Carpal Tunnel Syndrome Surgery (CACTuS). ESC Heart Failure. 10(1). 234–244. 14 indexed citations
15.
Rasmussen, Torsten B., Bertil Ladefoged, Anne M. Dybro, et al.. (2022). Transthyretin Gene Variants and Associated Phenotypes in Danish Patients with Amyloid Cardiomyopathy. SHILAP Revista de lepidopterología. 12(1). 1–11. 1 indexed citations
16.
Clemmensen, Tor Skibsted, Hans Eiskjær, Bertil Ladefoged, et al.. (2020). Prognostic implications of left ventricular myocardial work indices in cardiac amyloidosis. European Heart Journal - Cardiovascular Imaging. 22(6). 695–704. 64 indexed citations
17.
Povlsen, Jonas Agerlund, et al.. (2020). Prevalence and Prognostic Implications of Increased Apical-to-Basal Strain Ratio in Patients with Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement. Journal of the American Society of Echocardiography. 33(12). 1465–1473. 13 indexed citations
18.
Ladefoged, Bertil, Anne M. Dybro, Jonas Agerlund Povlsen, et al.. (2020). Diagnostic delay in wild type transthyretin cardiac amyloidosis – A clinical challenge. International Journal of Cardiology. 304. 138–143. 45 indexed citations
19.
Rasmussen, Torsten B., Henrik Vase, Bertil Ladefoged, et al.. (2020). Prevalence of hereditary transthyretin cardiac amyloidosis (mATTR) in Western Denmark. European Heart Journal. 41(Supplement_2). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026